Inserm-Transfert Initiative

Inserm Transfert Initiative (ITI) is a French venture capital firm dedicated to seed-stage financing for innovative life science companies. As the investment arm of Inserm Transfert, it focuses on bridging the gap between academic research and industrial development by supporting startups originating from Inserm and other leading research institutions. The firm provides both capital and strategic guidance to help early-stage biotech and medtech companies reach key value-inflection points. ITI's portfolio spans various therapeutic areas, including oncology, rare diseases, and digital health. By leveraging its deep connection to the French National Institute of Health and Medical Research, ITI facilitates the translation of high-quality science into clinical applications.